Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy
- 20 August 2019
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 54 (S2), 780-784
- https://doi.org/10.1038/s41409-019-0602-5
Abstract
Adoptive immunotherapy with CD19-targeted chimeric antigen receptor (CAR)-T cells has been successful in producing durable remissions in some patients with relapsed or refractory B cell malignancies. Despite the efficacy of CAR-T cell therapy, significant toxicities can occur. Cytokine release syndrome (CRS) and neurotoxicity are the most common toxicities and can range from self-limited fever to life threatening organ damage and death. Understanding the mechanisms underlying these toxicities can help guide and improve outcomes. In this review we describe CRS and neurotoxicity in patients with B cell malignancies treated with CD19 CAR-T cells in pivotal trials, and also provide insight into potential mechanisms associated with these toxicities based on studies conducted in a phase 1/2 clinical trial at the Fred Hutchinson Cancer Research Center.This publication has 19 references indexed in Scilit:
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T CellsCancer Discovery, 2017
- Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapyBlood, 2017
- Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adultsBlood, 2017
- The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted TherapyMediators of Inflammation, 2017
- Brain Pericytes As Mediators of NeuroinflammationTrends in Pharmacological Sciences, 2017
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cellsScience Translational Medicine, 2016
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsJCI Insight, 2016
- Current concepts in the diagnosis and management of cytokine release syndromeBlood, 2014
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie systemNature Reviews Molecular Cell Biology, 2009
- Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammationNature Medicine, 2006